Rifat Pamukcu
Rifat Pamukcu publishes mostly in Molecular Biology, Pharmacology and Genetics, on topics such as Inflammatory mediators and NSAID effects, Helicobacter pylori-related gastroenterology studies and Phosphodiesterase function and regulation.
- World rank
- #826,504 of 7,710,434 ranked researchers
- Rank in United States
- #274,964 of 1,627,098
- Works
- 54
- Citations
- 4.1k
- Citations per work
- 76.0
What does Rifat Pamukcu research?
Rifat Pamukcu's work is mostly in Biochemistry, Genetics and Molecular Biology (32%), Medicine (26%), Chemistry (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1935.6%
- Life Sciences1732.2%
- Health Sciences1426.3%
- Medicine1426.3%
- Physical Sciences35.9%
- Chemistry35.9%
- 1Molecular Biology24% of their works
- 2Pharmacology14% of their works
- 3Genetics8% of their works
- 4Surgery8% of their works
- 5Organic Chemistry6% of their works
- 6Oncology5% of their works
Research topics
- Inflammatory mediators and NSAID effects
- Helicobacter pylori-related gastroenterology studies
- Phosphodiesterase function and regulation
- Estrogen and related hormone effects
- Genomics, phytochemicals, and oxidative stress
- Synthesis and biological activity
- Gastrointestinal motility and disorders
- Protein Kinase Regulation and GTPase Signaling
Which keywords describe Rifat Pamukcu's research?
The keywords of their largest research topics: Inflammation, Cancer, Chemoprevention, Cyclooxygenase-2 Inhibitors, Prostaglandins, Transcriptional Regulation, Gastric Cancer and Helicobacter pylori.
- Ras Signaling
- Oxidative Stress
- Medicinal Chemistry
- Heterocyclic Compounds
- Receptor
- cAMP Signaling
- Helicobacter pylori
- Transcriptional Regulation
- Cyclooxygenase-2 Inhibitors
- Cancer
- Inflammation
- Chemoprevention
- Prostaglandins
- Gastric Cancer
- Cyclic Nucleotide Phosphodiesterases
- Estrogen
- Gastrointestinal Disorders
- Irritable Bowel Syndrome
- Nrf2
- Protein Kinases
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Inflammation394 topics
- Cancer242 topics
- Chemoprevention242 topics
- Cyclooxygenase-2 Inhibitors201 topic
- Prostaglandins201 topic
- Transcriptional Regulation122 topics
- Gastric Cancer111 topic
- Helicobacter pylori111 topic
- Cyclic Nucleotide Phosphodiesterases101 topic
- cAMP Signaling101 topic
- Estrogen91 topic
- Receptor91 topic
- Gastrointestinal Disorders41 topic
- Heterocyclic Compounds41 topic
- Irritable Bowel Syndrome41 topic
- Medicinal Chemistry41 topic
- Nrf241 topic
- Oxidative Stress41 topic
- Protein Kinases31 topic
- Ras Signaling31 topic
Where does Rifat Pamukcu work?
Rifat Pamukcu's main affiliation in the publication record is Pathways Behavioral Services, United States.
How many publications and citations does Rifat Pamukcu have?
OpenAlex counts 54 works and 4,102 citations for Rifat Pamukcu, an h-index of 29, ranking #826,504 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Rifat Pamukcu. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.